With the multiple myeloma drug’s climb from fifth- to second-line therapy, Carvykti uptake is set to expand. Legend Biotech CEO Ying Huang discusses timing of a crucial supply bump.
AbbVie-backed effort spotlights night symptoms of Parkinson’s
The MM+M/Swoop 2024 Healthcare Marketers Trend Report revealed the marcoms tech stack is playing a lead role in engaging physicians, as traditional tactics make way for digital.